Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 53567-47-8
2. Alfospas
3. Maiorad
4. Tiropramide Hcl
5. Tiropramide Hydrochloride [mi]
6. Tiropramide Hydrochloride [mart.]
7. Tiropramide Hydrochloride [who-dd]
8. Einecs 260-634-0
9. 57227-16-4
10. 9523013y6r
11. Benzenepropanamide, Alpha-(benzoylamino)-4-(2-(diethylamino)ethoxy)- N,n-dipropyl-, Hydrochloride, (+/-)-
12. N-(3-(4-(2-(diethylamino)ethoxy)phenyl)-1-(dipropylamino)-1-oxopropan-2-yl)benzamide Hydrochloride
13. Tiropramide Hydrochloride (jan)
14. Tiropramide Hydrochloride [jan]
15. Unii-9523013y6r
16. Maiorad (tn)
17. (+-)-alpha-benzoylamino-4-(2-(diethylamino)ethoxy)-n,n-dipropylbenzenepropanamide Hcl
18. N-[2-[4-(2-diethylaminoethoxy)phenyl]-1-(dipropylcarbamoyl)ethyl]benzamide Hydrochloride
19. Benzenepropanamide, Alpha-(benzoylamino)-4-(2-(diethylamino)ethoxy)-n,n-dipropyl-, Hydrochloride, (+-)-
20. Mls006010762
21. Schembl2255455
22. Dtxsid70972684
23. Mfcd01741847
24. (1)-2-benzamido-3-(p-(2-(diethylamino)ethoxy)phenyl)-n,n-dipropylpropionamide Hydrochloride
25. Dl-alpha-benzamido-p-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide Hydrochloride
26. Ac-32033
27. Smr004701453
28. Ft-0675253
29. T2978
30. D08608
31. T72584
32. Q27271728
33. Dl-.alpha.-benzamido-p-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide Hydrochloride
34. N-(3-(4-(2-(diethylamino)ethoxy)phenyl)-1-(dipropylamino)-1-oxopropan-2-yl)benzamidehydrochloride
35. N-[2-[4-(2-diethylaminoethoxy)phenyl]-1-(dipropylcarbamoyl)ethyl]benzamidehydrochloride
36. N-[3-[4-[2-(diethylamino)ethoxy]phenyl]-1-(dipropylamino)-1-oxopropan-2-yl]benzamide;hydrochloride
37. N-[3-{4-[2-(diethylamino)ethoxy]phenyl}-1-(dipropylamino)-1-oxopropan-2-yl]benzenecarboximidic Acid--hydrogen Chloride (1/1)
| Molecular Weight | 504.1 g/mol |
|---|---|
| Molecular Formula | C28H42ClN3O3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 15 |
| Exact Mass | 503.2914699 g/mol |
| Monoisotopic Mass | 503.2914699 g/mol |
| Topological Polar Surface Area | 61.9 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 561 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
A Tiropramide Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiropramide Hydrochloride, including repackagers and relabelers. The FDA regulates Tiropramide Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiropramide Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tiropramide Hydrochloride supplier is an individual or a company that provides Tiropramide Hydrochloride active pharmaceutical ingredient (API) or Tiropramide Hydrochloride finished formulations upon request. The Tiropramide Hydrochloride suppliers may include Tiropramide Hydrochloride API manufacturers, exporters, distributors and traders.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tiropramide Hydrochloride Drug Master File in Korea (Tiropramide Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tiropramide Hydrochloride. The MFDS reviews the Tiropramide Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Tiropramide Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tiropramide Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tiropramide Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tiropramide Hydrochloride suppliers with KDMF on PharmaCompass.
Tiropramide Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiropramide Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiropramide Hydrochloride GMP manufacturer or Tiropramide Hydrochloride GMP API supplier for your needs.
A Tiropramide Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Tiropramide Hydrochloride's compliance with Tiropramide Hydrochloride specifications and serves as a tool for batch-level quality control.
Tiropramide Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Tiropramide Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiropramide Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiropramide Hydrochloride EP), Tiropramide Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiropramide Hydrochloride USP).
LOOKING FOR A SUPPLIER?
